FutureWorld (FWDG) CB Scientific to Deliver Affordable Legal Global Access to Complete Cannabis Testing for Potency & Detection

CB Scientific & uPrep Make History by Giving Access to Patients & Growers to an Advanced Scientific Laboratory from Anywhere Without Boundaries Affordably

Denver, Colorado, Sept. 8, 2015 (GLOBE NEWSWIRE) -- FutureWorld Corp. (FWDG), a cannabis technology accelerator and a leading provider of advanced technologies and solutions to the global cannabis industry, announced today that its subsidiary, CB Scientific, a leading Cannabis (hemp) Science and Technology company, has signed an exclusive global distribution agreement with uPREP Laboratory Test Kits Inc. The agreement pairs uPrep's high-quality testing product portfolio and its industry-leading scientific laboratory testing, which enables quality assurance and patient safety within Cannabinoid Medicine, with CB Scientific's technological innovations and marketing expertise.

Under the terms of the agreement, CB Scientific will employ its sales and marketing, eCommerce expertise, and the strength of its relationships with the cannabis and hemp community, to market and distribute the uPrep's test kit product portfolio, globally. uPrep's product portfolio distributed by CB Scientific includes;

  • THC/CBD/CBN Test kit - Lab tested test kits for complete breakdown of the potency level
  • Terpene Test kit - Lab tested test kits for complete terpene profile & residual solvents
  • Pesticide Test kit - Lab tested test kits for insecticides, fungicides & harmful chemicals
  • Hair Toxicology Test kit - Lab tested test kits for drug use pattern 
  • Illicit Drug Urinalysis Test kit - Selftest & instand test kits for 7 illicit drugs and 5 prescription drugs

For more information, please visit http://www.uprep.ca

"CB Scientific is excited to offer the global cannabis (hemp) community access to uPrep's leading portfolio of tests legally and without boundaries. The addition of the uPreps laboratory testing kits and tools supports our strategy to augment our current portfolio with quality products that accelerate Cannabinoid Medicine industry research and safety testing programs," said Henry Biza, CEO of CB Scientific. "We look forward to working with uPrep through this relationship."

"This agreement allows us to provide more customers with access to high-quality testing kit products through CB Scientific's expanded eCommerce and distribution networks, "said Calum Hughes (Co-Director of uPREP).  "In addition, this will provide us the flexibility to devote more resources to our primary focus areas."

"We are excited to announce this worldwide distribution agreement. In our humble opinion, CB Scientific has the perfect blend of scientific knowledge and business acumen to represent and distribute the uPREP products worldwide. It is clear to us that CB Scientific is a company that achieves what it sets out to do. This, paired with a shared vision of quality and patient safety, is the perfect synergy that we were looking for. We are very excited to see the success to come."  Mr. Donald Schultz (Co-Director of uPREP).

Transition of the sales and marketing of uPrep's portfolio (of products and services) to CB Scientific is expected to take place in October, 2015. The testing products and services are available in all States and Countries. The unique patented process creates a global legal environment to offer complete testing of cannabis related products. 

For more information on how to access this portfolio of products, please email us at; sales@cbscientific.com. 

About uPREP Laboratory Test Kits, Inc. 

uPREP Laboratory Test Kits Inc, (www.uprep.ca) is a privately held corporation based in British Columbia, Canada. uPREP is on the leading edge of development for novel home preparation scientific laboratory test kits that enable quality assurance and patient safety within Cannabinoid Medicine. The uPREP vision is that every patient should be enabled with the science and knowledge of what is contained within their medicine. The novel, patented uPREP Kits walk the user through a safe, anonymous, and legal home preparation method to render the samples under the legal threshold of 10 parts per million.  The samples can then be legally shipped to the uPREP gold standard laboratory and the results posted for download on the uPREP website. Included in the purchase of the kit is the laboratory where the proprietary re-hydration, testing and analysis happens. The uPREP laboratory boasts the highest standard Ultra High Performance Liquid Chromatography, (HPLC), Gas Chromatography (GC), and Mass Spectrometry analysis by our Research and Development team of PhD Scientists. There are many more products currently in the pipeline and we are very excited to see the market enjoy the science and patient safety that they bring to medicine. 

To request further information about uPREP and current and future products, please email us at  info@uprep.ca, 1-888-501-2644

About CB Scientific Inc.

CB Scientific (www.cbscientific.com) is a wholly owned subsidiary of FutureWorld Corp based in Denver, Colorado. CB Scientific is continuing to develop new technologies specifically for cannabis (hemp) analytics. CB Scientific believes every product sold to patients as "Medical Quality" should be inspected for health benefits, safety, consistency, purity, potency and packaged properly for distribution. CB Scientific has worked with many of the cannabis industry leaders in the country and have also been featured in cannabis industry publications including High Times Magazine, Culture and many trade publications, on-air interviews and panel discussions across the United States. CB Scientific's focus has been the education and safety of consumers combined with innovation to put power into the hands of the patients. Values that FutureWorld is pleased to embrace while ever striving to raise the bar of cannabis analytics even higher.

The test kits have been featured on ABC, CBS, Fox, Telemundo, The Adam Dunn Show, as well as in publications such as High Times, Culture and Forbes Magazine. In December 2014, just 94 days after its launch the THC & CBD Test Kits were awarded "Product of the Year" by the Cannabis Business Awards in Colorado.

To request further information about CB Scientific, please email us at info@cbscientific.com, log onto our website athttp://www.cbscientific.com or visit us on FB at cbscientificinc and Twitter @cbscientific.

About FutureWorld Corp. 

FutureWorld (FWDG), a Delaware corporation, is a leading provider of advanced technologies and solutions to the global cannabis industry. FutureWorld, together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of cannabis related products and services, such as industrial Hemp. FutureWorld, through its subsidiaries, provides personal and professional THC and CBD test kits, pharmaceutical grade CBD oil solutions, SafeVape vaporizers, smart sensor technology, communication network, surveillance security, data analysis for smart cultivation and consultation for the industrial hemp and legal medicinal cannabis. Our wireless agricultural smart sensor networks offer precision to the agriculture, irrigation systems, and greenhouses for the global cannabis and hemp industry. FutureWorld and its subsidiaries do not grow, distribute or sell marijuana.

As the only Cannabis Technology Accelerator, FutureWorld will incubate and fund leading technologies, products, and services for Cannabis industry (Industrial Hemp) for foreseeable future; bringing value to its core and its shareholders.

To request further information about FutureWorld, please email us at info@futureworldcorp.com, log onto our website at http://www.futureworldcorp.com or visit us at our Facebook page at futureworldcorp or on Twitter @futureworldinc.

Forward-Looking Statements 

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets. This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.


Contact Data